| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_af99df08b153738cd418446a75d09bfc |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D253-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D253-06 |
| filingDate |
1977-06-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1981-04-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2258681246d404ace45929977aa9f27c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ba2350eee5468d176f339f2a3c00c962 |
| publicationDate |
1981-04-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-4263295-A |
| titleOfInvention |
Psychoactive 3-(1-2-diarylethyl)-1,4,5,6-tetrahydro-1,2,4-triazines and their method of use |
| abstract |
Novel triazine compounds useful for treating central nervous system depression and anxiety in a mammal, their method of use and pharmaceutical compositions thereof. |
| priorityDate |
1977-06-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |